Recent Updates
Recently added Catalysts
LH Positive Sentiment Score: 80/100

Document FOR IMMEDIATE RELEASE LabCorp Contacts Media Kimbrel Arculeo - 336-436-8263 Media Labcorp.com Investors Relations Christin O'Donnell - 336-436-5076 Investor Labcorp.com LABCORP TO SPEAK AT THE 42ND

Tuesday, January 2, 2024 1 min read
Key Takeaway: Labcorp (NYSE LH) announced its participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference, where members of its executive management will engage in a fireside chat. The event is scheduled for January 9 at 4:30 p.m. PT. A live audio webcast will be available on the company's Investor Relations website, allowing stakeholders and the public to follow the discussion. Labcorp is recognized for its extensive laboratory services, supporting medical professionals and researchers worldwide.

Market Sentiment Analysis

POSITIVE FACTORS

  • Labcorp is participating in a prestigious industry event, the J.P. Morgan Healthcare Conference.
  • The company has a strong track record with over 80% of new drugs approved by the FDA in 2022.
  • Labcorp employs over 60,000 professionals, indicating strong operational capacity.
  • The CEO will engage in direct communication with stakeholders via the webcast.

Full Press Release Details

Media Kimbrel Arculeo - 336-436-8263
Investors Relations Christin O'Donnell - 336-436-5076
Investor Labcorp.com
LABCORP TO SPEAK AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
BURLINGTON, N.C., Jan. 2, 2024 - Labcorp (NYSE LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9 at 4 30 p.m. (PT).
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
Labcorp (NYSE LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.

Frequently Asked Questions

When will Labcorp speak at the J.P. Morgan Healthcare Conference?

Labcorp will speak on January 9, 2024, at 4:30 p.m. PT.

Where can I watch Labcorp's fireside chat?

You can watch the fireside chat live at ir.Labcorp.com.

How many employees does Labcorp have?

Labcorp has more than 60,000 employees globally.

In how many countries does Labcorp operate?

Labcorp serves clients in over 100 countries.

What percentage of new FDA drugs did Labcorp work on in 2022?

Labcorp worked on over 80% of the new drugs approved by the FDA in 2022.

Tags: LH Viatris Investor Conferences Healthcare Labcorp J.P. Morgan Healthcare Conference NYSELH laboratory services healthcare investors
Last updated: Jan 2, 2024